SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling

Cell Biochemistry and Biophysics

Volumn 73, Issue 1, 2015, Pages 205-212

  Liu, Hongwei ^a   Liu, Zhixiong ^a   Jiang, Bing ^a   Peng, Renjun ^a   Ma, Zhiming ^a   Lu, Jingchen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cell migration; EMT; Invasion; Metastasis; SOX9; Catenin

Indexed keywords

BETA CATENIN; SOX9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX9; WNT PROTEIN;

CELL MOTION; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; GLIOMA; HUMAN; METABOLISM; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOMA; HUMANS; SOX9 TRANSCRIPTION FACTOR; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84939251433     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-015-0647-z     Document Type: Article

References (23)

1. Wei, J., Gabrusiewicz, K., & Heimberger, A. (2013). The controversial role of microglia in malignant gliomas. Clinical and Developmental Immunology,2013, 285246.
2. Kettenmann, H., et al. (2011). Physiology of microglia. Physiological Reviews,91(2), 461–553.
3. Steeg, P. S. (2006). Tumor metastasis: Mechanistic insights and clinical challenges. Nature Medicine,12(8), 895–904.
4. Li, X., et al. (2013). SOX2 promotes tumor metastasis by stimulating epithelial-to-mesenchymal transition via regulation of WNT/beta-catenin signal network. Cancer Letters,336(2), 379–389.
5. Hersmus, R., et al. (2008). FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). Journal of Pathology,215(1), 31–38.
6. Jay, P., Berta, P., & Blache, P. (2005). Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells. Cancer Research,65(6), 2193–2198.
7. Thomsen, M. K., et al. (2010). SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Research,70(3), 979–987.
8. Kimura, M. S., Mutoh, H., & Sugano, K. (2011). SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans. Journal of Gastroenterology,46(11), 1292–1299.
9. Chakravarty, G., et al. (2011). Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Experimental Biology and Medicine (Maywood),236(2), 145–155.
10. Sutter, R., et al. (2010). Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene,29(12), 1845–1856.
11. Schlierf, B., et al. (2007). Expression of SoxE and SoxD genes in human gliomas. Neuropathology and Applied Neurobiology,33(6), 621–630.
12. Wang, L., et al. (2012). Oncogenic role of SOX9 expression in human malignant glioma. Medical Oncology,29(5), 3484–3490.
13. Shi, G., et al. (2013). Expression and functional role of Sox9 in human epidermal keratinocytes. PLoS One,8(1), e54355.
14. Jung, M., et al. (2007). In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Molecular Biology,8, 47.
15. Zhao, J. H., et al. (2011). Knockdown of beta-catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1 alpha. Cancer Investigation,29(6), 377–382.
16. Wang, H., et al. (2013). SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/beta-catenin activation in breast cancer. Journal of Biological Chemistry,288(9), 6478–6487.
17. Galera-Ruiz, H., et al. (2012). WNT pathway in laryngeal squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otorhinolaryngologica Italica,32(2), 122–123.
18. Fu, Y., et al. (2011). Beta-catenin as a potential key target for tumor suppression. International Journal of Cancer,129(7), 1541–1551.
19. Valenta, T., Hausmann, G., & Basler, K. (2012). The many faces and functions of beta-catenin. EMBO Journal,31(12), 2714–2736.
20. Capaccione, K. M., et al. (2014). Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma. Oncotarget,5(11), 3636–3650.
21. Yang, J., & Weinberg, R. A. (2008). Epithelial–mesenchymal transition: At the crossroads of development and tumor metastasis. Developmental Cell,14(6), 818–829.
22. Polette, M., et al. (2007). Beta-catenin and ZO-1: Shuttle molecules involved in tumor invasion-associated epithelial–mesenchymal transition processes. Cells Tissues Organs,185(1–3), 61–65.
23. Brabletz, T., et al. (2001). Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proceedings of the National Academy Sciences USA,98(18), 10356–10361.